Cell Surface Markers Market To Reach US$ 44,373.4 Million By 2027 - Coherent Market Insights

1. CELL SURFACE MARKERS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Cell Surface Markers Market - Overview The study of cell surface markers is crucial in the evaluation of cell proliferation, abnormal cell populations and quantification and assessment of minimal residual diseases. Growing focus on disease prevention and reduction of overall healthcare expenditure has resulted in an increase in acceptance and adoption of analytical technologies such as cell surface marker analysis and in vitro diagnostics tools. The global Cell Surface Markers Market is estimated to account for US$ 24,961.0 Mn in terms of value in 2020 and is expected to reach US$ 44,373.4 Mn by the end of 2027. Global Cell Surface Markers Market: Drivers Increasing prevalence of cancer is expected to propel growth of the global cell surface markers market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Global Cell Surface Markers Market: Opportunities Advances in surface markers are expected to offer lucrative growth opportunities for players in the global cell surface markers market. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/cell- surface-markers-market-3912 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Cell Surface Markers Market: Restraints Complexity in the use of flow cytometers is expected to hinder growth of the market. Lack of expertise in the use of such equipment, especially in markets with low awareness such as some parts of Asia Pacific and Middle East has resulted in less use and purchase of high- end flow cytometers in these regions. In recent years, the complexity of flow cytometry methodologies has significantly increased, particularly in relation to the quantity of simultaneous measurements available in such devices. Furthermore, the areas of spectral overlap, accuracy of collected data, issues of complex data processing and cluster identification automation can create several problems in the use of flow cytometry both in research and disease diagnosis. Key Takeaways: The global cell surface markers market was valued at US$ 23,037.4 Mn in 2019 and is forecast to reach a value of US$ 44,373.4 Mn by 2027 at a CAGR of 8.6% between 2020 and 2027. Major factor driving the growth of global cell surface markers market during the forecast period include growing automation in laboratories, and increasing adoption of in vitro diagnostics North America held dominant position in the global cell surface markers market in 2019, accounting for 37.5% share in terms of value, followed by Europe and Asia Pacific, respectively. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3912 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Market Trends Major players in the market are focused on product approval and launch to expand their product portfolio. For instance, in April 2019, Beckman Coulter received 510(k) clearance from the U.S. Food and Drug Administration for its Early Sepsis Indicator, a hematology-based cellular biomarker that is designed to help emergency department physicians identify patients with sepsis or at increased risk of developing sepsis. Major players in the market are focused on adopting various marketing strategies to enhance their market share. Global Cell Surface Markers Market: Competitive Landscape Major players operating in the global cell surface markers market include, Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Sysmex Corporation, and Thermo Fisher Scientific, Inc. Global Cell Surface Markers Market: Key Developments September 2019: F. Hoffmann-La Roche Ltd presented OCREVUS (ocrelizumab) biomarker data that highlights new insights into the biology of multiple sclerosis at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held in Stockholm, Sweden. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3912 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved